• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

机构信息

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.

Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.

出版信息

Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.

DOI:10.1126/science.abf4063
PMID:33408181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7919858/
Abstract

Understanding immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for improving diagnostics and vaccines and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥6 months after infection. Immunoglobulin G (IgG) to the spike protein was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month after symptom onset. SARS-CoV-2-specific CD4 T cells and CD8 T cells declined with a half-life of 3 to 5 months. By studying antibody, memory B cell, CD4 T cell, and CD8 T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.

摘要

了解针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的免疫记忆对于改进诊断和疫苗以及评估 COVID-19 大流行的未来可能进程至关重要。我们分析了 188 例 COVID-19 病例的 254 个样本中循环免疫记忆的多个隔室,包括感染后≥6 个月的 43 个样本。针对刺突蛋白的免疫球蛋白 G (IgG) 在 6 个月以上相对稳定。与症状出现后 1 个月相比,刺突特异性记忆 B 细胞在 6 个月时更为丰富。SARS-CoV-2 特异性 CD4 T 细胞和 CD8 T 细胞的半衰期为 3 至 5 个月。通过综合研究 SARS-CoV-2 抗体、记忆 B 细胞、CD4 T 细胞和 CD8 T 细胞的记忆,我们观察到 SARS-CoV-2 免疫记忆的每个组成部分都表现出不同的动力学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/191b43a66ee9/abf4063-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/c263e06208d0/abf4063-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/bb3d16c5d841/abf4063-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/4772fb070417/abf4063-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/942f0259dd6d/abf4063-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/191b43a66ee9/abf4063-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/c263e06208d0/abf4063-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/bb3d16c5d841/abf4063-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/4772fb070417/abf4063-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/942f0259dd6d/abf4063-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/709a/7919858/191b43a66ee9/abf4063-F5.jpg

相似文献

1
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
2
Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.轻度 COVID-19 患者和未暴露供体中的免疫记忆揭示了 SARS-CoV-2 感染后持续的 T 细胞反应。
Front Immunol. 2021 Mar 11;12:636768. doi: 10.3389/fimmu.2021.636768. eCollection 2021.
3
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.SARS-CoV-2 感染后长达 9 个月的稳健且具有功能性的免疫记忆:一项东南亚纵向队列研究。
Front Immunol. 2022 Feb 3;13:817905. doi: 10.3389/fimmu.2022.817905. eCollection 2022.
4
Distinct immune memory induced by SARS-CoV-2 in convalescent liver transplant recipients.新冠康复期肝移植受者体内由新冠病毒诱导产生的独特免疫记忆
Front Immunol. 2025 Apr 2;16:1420150. doi: 10.3389/fimmu.2025.1420150. eCollection 2025.
5
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.纵向分析显示,SARS-CoV-2 感染后具有持久的抗体反应和记忆 B 细胞和 T 细胞,可产生持久和广泛的免疫记忆。
Cell Rep Med. 2021 Jul 20;2(7):100354. doi: 10.1016/j.xcrm.2021.100354. Epub 2021 Jul 3.
6
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
7
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.COVID-19 恢复期患者体内 SARS-CoV-2 抗体动态变化和 B 细胞记忆应答特征。
Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.
8
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.采用 ex vivo ELISpot assay 检测 COVID-19 恢复期患者和未接触者的 SARS-CoV-2 特异性 T 细胞免疫。
Clin Microbiol Infect. 2021 Jul;27(7):1029-1034. doi: 10.1016/j.cmi.2021.03.010. Epub 2021 Apr 2.
9
Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.2019冠状病毒病患者感染九个月后抗体和细胞免疫反应的持续性
J Infect Dis. 2021 Aug 16;224(4):586-594. doi: 10.1093/infdis/jiab255.
10
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.感染后长达八个月对新冠病毒的免疫记忆评估。
bioRxiv. 2020 Dec 18:2020.11.15.383323. doi: 10.1101/2020.11.15.383323.

引用本文的文献

1
Antibody and B-Cell Responses to PHH-1V81 XBB.1.16-Adapted SARS-CoV-2 Booster Vaccination Are Associated With Variant Neutralization.针对PHH-1V81 XBB.1.16适应性严重急性呼吸综合征冠状病毒2加强疫苗接种的抗体和B细胞反应与变体中和相关。
J Med Virol. 2025 Sep;97(9):e70583. doi: 10.1002/jmv.70583.
2
Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination.新型冠状病毒2感染及mRNA疫苗接种后的体液和记忆B细胞反应
Vaccines (Basel). 2025 Jul 28;13(8):799. doi: 10.3390/vaccines13080799.
3
Immune Responses of Dendritic Cells to Zoonotic DNA and RNA Viruses.

本文引用的文献

1
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
2
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.REGN-COV2,一种中和抗体鸡尾酒疗法,用于治疗门诊新冠患者。
N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.
3
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.轻度 COVID-19 后,SARS-CoV-2 特异性免疫记忆仍具有功能性。
树突状细胞对人畜共患DNA和RNA病毒的免疫反应
Vet Sci. 2025 Jul 24;12(8):692. doi: 10.3390/vetsci12080692.
4
Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节
Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.
5
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.一种超长重链牛抗体可中和新冠病毒,并与沙贝病毒广泛反应。
bioRxiv. 2025 Jul 17:2025.01.03.631215. doi: 10.1101/2025.01.03.631215.
6
Antibodies against SARS-CoV-2 in children and adolescents: a one-year longitudinal study.儿童和青少年中针对严重急性呼吸综合征冠状病毒2的抗体:一项为期一年的纵向研究。
BMJ Paediatr Open. 2025 Aug 11;9(1):e003392. doi: 10.1136/bmjpo-2025-003392.
7
Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial.雾化腺病毒载体新冠疫苗和肌肉注射mRNA疫苗二价加强针的安全性和免疫原性:一项随机开放标签临床试验。
Nat Commun. 2025 Aug 7;16(1):7281. doi: 10.1038/s41467-025-62698-7.
8
Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.人类效应性和记忆性CD8 T细胞分化过程中CD45异构体的调控:对T细胞命名的影响。
Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2322982122. doi: 10.1073/pnas.2322982122. Epub 2025 Aug 5.
9
Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.COVID-19患者前瞻性队列中的恢复期血浆疗法与长期SARS-CoV-2抗病毒免疫反应
Curr Res Microb Sci. 2025 Jul 9;9:100440. doi: 10.1016/j.crmicr.2025.100440. eCollection 2025.
10
Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers.探索对SARS-CoV-2的免疫反应:来自一组委内瑞拉混血志愿者中接种国药集团(BBIBP-CorV)疫苗个体的见解。
Biomedicines. 2025 Jun 25;13(7):1550. doi: 10.3390/biomedicines13071550.
Cell. 2021 Jan 7;184(1):169-183.e17. doi: 10.1016/j.cell.2020.11.029. Epub 2020 Nov 23.
4
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
5
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.感染 SARS-CoV-2 的恒河猴中的血管疾病和血栓形成。
Cell. 2020 Nov 25;183(5):1354-1366.e13. doi: 10.1016/j.cell.2020.10.005. Epub 2020 Oct 9.
6
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染:一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
7
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters.RECON-COV2 抗体可预防和治疗恒河猴和仓鼠感染 SARS-CoV-2。
Science. 2020 Nov 27;370(6520):1110-1115. doi: 10.1126/science.abe2402. Epub 2020 Oct 9.
8
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.COVID-19 患者血清和唾液中针对 SARS-CoV-2 刺突抗原的抗体反应持续存在。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe5511.
9
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.在致死性 COVID-19 患者中的病毒存在和免疫病理学:一项前瞻性尸检队列研究。
Lancet Microbe. 2020 Nov;1(7):e290-e299. doi: 10.1016/S2666-5247(20)30144-0. Epub 2020 Sep 25.
10
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.